Saturday 17 October 2026
Export IONM’s income statement to Excel — free account
Assure Holdings Corp.
IONM Healthcare Medical Care Facilities
Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow IONM
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 3 | 4 | 2 | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | 39.46 | 2.04 | 0.20 | 2.84 | (4.52) | (24.39) |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 10.57 | 2.17 | 8.95 | 4.64 |
Altman Z″-Score (non-manufacturers) |
— | — | 7.70 | 4.18 | 0.42 | 4.94 | (6.85) | (62.84) |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | (0.90) | — | 2.50 | — | — |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | (54.40) | (15.76) | (1.96) | (5.33) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 1.94 | 2.19 | 0.77 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 3.05 | 3.04 | 1.04 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 11.13 | 2.53 | 35.31 | 60.08 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | (15.49) | (5.52) | (2.24) | (3.04) |
EV/FCF |
0.00 | 0.00 | 0.00 | 0.00 | (13.76) | (5.39) | (2.22) | (2.99) |
Quick Ratio |
3.63 | 7.05 | 6.90 | 2.68 | 2.57 | 8.60 | 3.23 | 0.17 |
Current Ratio |
3.63 | 7.10 | 6.93 | 2.91 | 3.29 | 10.22 | 4.68 | 0.30 |
Net Debt/EBITDA |
0.07 | (0.04) | 0.01 | 3.52 | (0.13) | (11.34) | (0.84) | (0.71) |
Debt/Assets |
5.32% | 0.00% | 2.97% | 23.17% | 18.88% | 29.85% | 54.95% | 189.77% |
Debt/Equity |
0.11 | 0.19 | 0.11 | 1.02 | 0.33 | 0.50 | 2.44 | (0.93) |
Asset Turnover |
0.42 | 5.03 | 0.83 | 0.54 | 0.09 | 0.71 | 0.01 | 0.02 |
Operating CF/Net income |
0.24 | 0.28 | 0.19 | (1.56) | 0.21 | 4.85 | 0.25 | 0.19 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.09) | (0.31) | 0.00 | (0.01) | 0.00 |
Interest Coverage |
0.00 | 0.00 | 1,315.22 | 9.41 | (30.57) | (1.97) | (13.45) | (9.89) |
| 118.69% | (196.42%) | 82.20% | 34.27% | (102.73%) | (11.44%) | (174.96%) | 528.43% | |
| 23.52% | (175.29%) | 24.12% | 8.27% | (38.54%) | (6.72%) | (82.89%) | (164.20%) | |
ROIC |
0.00% | 0.00% | 0.00% | 7.30% | (47.83%) | (3.38%) | (77.04%) | 0.00% |
Return on Tangible Assets |
88.06% | (32.33%) | 18.80% | 12.17% | (84.74%) | (8.02%) | (164.58%) | 168.30% |
Average Days of Receivables |
297.32 | 436.27 | 619.52 | 638.18 | 1,565.54 | 349.42 | 11,735.02 | 5,154.37 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
24.56% | 28.69% | 41.31% | 55.64% | 306.50% | 54.42% | 3,198.51% | 5,303.53% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.17 | 0.21 | 0.17 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 7.10% | 15.55% | 6.55% | 218.47% | (117.65%) |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 0.29 | 1.06 | (13.62) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 426.25 |
Earnings Yield |
(41.30%) | (41.30%) | (41.30%) | (41.30%) | (41.30%) | (4.11%) | (714.38%) | (2,514.50%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | (7.65%) | (21.60%) | (177.86%) | (432.68%) |
Revenue per Share |
3.05 | 1.90 | 30.64 | 928.01 | 175.32 | 895.46 | 11.27 | 1.07 |
Operating CF per Share |
0.42 | (0.19) | 1.68 | (221.36) | (158.41) | (410.21) | (177.37) | (21.21) |
Capex per Share |
0.00 | 0.00 | 0.00 | (2.51) | (15.87) | 0.00 | (1.91) | 0.00 |
Free Cash Flow per Share |
0.42 | (0.19) | 1.68 | (223.87) | (174.28) | (410.21) | (179.28) | (21.21) |
Cash per Share |
0.04 | 0.03 | 1.72 | 3.09 | 218.21 | 123.31 | 21.65 | 0.52 |
Shareholders Equity per Share |
1.65 | 0.29 | 16.28 | 526.96 | 955.67 | 888.22 | 130.74 | (64.49) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.65 | 0.29 | 16.28 | 526.96 | 955.67 | 888.22 | 130.74 | (64.49) |
Free Cash Flow |
0.64 | (1.23) | 0.60 | (4.28) | (3.50) | (13.37) | (7.49) | (5.04) |
Working Capital |
2.82 | 13.21 | 16.39 | 22.11 | 17.39 | 34.29 | 18.29 | (15.49) |
Capital Expenditures |
(0.08) | (0.03) | (0.22) | (0.05) | (0.32) | — | (0.08) | — |
Net Current Asset Value |
1.42 | (0.27) | 3.63 | (0.61) | 10.54 | 18.55 | 4.48 | (16.13) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 | 0.17 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.25 | 0.41 | 0.60 | 2.57 | 2.85 | 14.20 | 1,219.33 | 0.00 |
Cash ROIC |
22.39% | (49.49%) | 8.47% | (20.95%) | (11.70%) | (28.20%) | (38.05%) | 529.28% |
Accounts Receivable Turnover |
0.50 | 1.33 | 0.65 | 0.72 | 0.15 | 1.36 | 0.02 | 0.03 |
Accounts Payable Turnover |
0.73 | 2.02 | 1.38 | 1.51 | 2.19 | 5.65 | 0.99 | 0.47 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
103.99 | 323.64 | 278.10 | 321.54 | 132.45 | 55.93 | 420.79 | 1,104.54 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
9.47 | 9.47 | 16.80 | 24.74 | 23.05 | 21.53 | 21.54 | 9.37 |
Average Payables |
1.12 | 1.12 | 2.11 | 3.29 | 3.62 | 2.53 | 2.56 | 5.17 |
Average Assets |
11.30 | 2.51 | 13.17 | 32.85 | 39.01 | 41.03 | 36.33 | 15.88 |
Average Common Equity |
2.24 | 2.24 | 3.86 | 7.93 | 14.64 | 24.08 | 17.21 | (4.93) |
Columns are period end dates